Laden...
Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH). Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults 09/29/2020 06:00 PM EDTA Phase 1 clinical trial enrolled 40 healthy volunteers.
|
Laden...
Laden...
© 2024